2022
DOI: 10.1016/j.carrev.2022.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Mechanical Circulatory Support Used Before Versus After Primary Percutaneous Coronary Intervention in Patients with Cardiogenic Shock From ST-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(4 citation statements)
references
References 43 publications
0
4
0
Order By: Relevance
“…Current guidelines advised that MCS could be used in patients who occur acute myocardial infarction or CS (9,13). Recently, a meta-analysis showed the mortality is lower in patients with ST-elevation myocardial infarction complicated by cardiogenic shock who undergoing primary percutaneous coronary intervention with ECMO (15). Although, some studies explored the effective and safety of ECMO support in elective HR-PCI patients, there results still are limited.…”
Section: Discussionmentioning
confidence: 99%
“…Current guidelines advised that MCS could be used in patients who occur acute myocardial infarction or CS (9,13). Recently, a meta-analysis showed the mortality is lower in patients with ST-elevation myocardial infarction complicated by cardiogenic shock who undergoing primary percutaneous coronary intervention with ECMO (15). Although, some studies explored the effective and safety of ECMO support in elective HR-PCI patients, there results still are limited.…”
Section: Discussionmentioning
confidence: 99%
“…In patients with acute myocardial infarction complicated with CS, VA-ECMO combined with IABP instrumental circulatory support significantly reduced mortality compared with VA-ECMO alone ( 19 ). For STEMI patients with CS undergoing PCI, the application of Impella or VA-ECMO before PCI significantly reduced mortality, whereas the use of IABP before and after PPCI had no effect on mortality ( 20 ). Huang et al reported that for STEMI patients, ECMO implantation prior to PCI improved survival at six months and improved short- and long-term outcomes ( 21 ).…”
Section: Discussionmentioning
confidence: 99%
“…A meta-analysis on the basis of observational data involving 1352 patients undergoing MCS for AMI-CS (IABP: n=956, Impella: n=203, VA-ECMO: n=193) found that VA-ECMO initiation before PCI was associated with a significantly lower risk of mortality. 54 By contrast, aggressive CS management with early VA-ECMO initiation did not translate to improved outcomes in the individual-patient data meta-analysis of AMI-CS trials. 39 These findings call for a more vigorous assessment of timing in clinical trial protocols also in studies involving CS pathogeneses other than myocardial infarction, keeping in mind the association of VA-ECMO and increased LV afterload.…”
Section: Va-ecmo In Postcardiotomy Csmentioning
confidence: 96%